CNTA · Centessa Pharmaceuticals plc
Market Cap
$6.27B
Shares
154.73M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-12 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-02-13 | 2026-02-09 | |
| 8-K/A | 2026-01-07 | 2025-12-05 | |
| 8-K | 2025-12-11 | 2025-12-05 | |
| 8-K | 2025-11-24 | — | |
| 8-K | 2025-11-13 | 2025-11-11 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-20 | — | |
| 8-K | 2025-06-17 | 2025-06-16 | |
| 8-K | 2025-05-29 | 2025-05-27 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-05-06 | 2025-06-20 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-02-21 | 2025-02-14 | |
| 10-Q/A | 2025-02-14 | 2024-09-30 | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-12-30 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 10-Q/A | 2024-10-18 | 2024-06-30 | |
| 8-K | 2024-09-13 | 2024-09-12 | |
| 8-K | 2024-09-10 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-25 | — | |
| 8-K | 2024-06-10 | 2024-06-05 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| DEF 14A | 2024-05-09 | 2024-06-25 | |
| 8-K | 2024-04-24 | 2024-04-23 | |
| 8-K | 2024-04-22 | — | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-02-09 | — | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2023-12-11 | 2023-12-10 | |
| 8-K | 2023-11-13 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-25 | — |
Showing 1–50 of 95 filings